NIURKA DEL SOL: Open Payments
NPI 1437561503 · CASSELBERRY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 30 payments from 10 companies in 2025. Trend: 2023 $76 · 2024 $482 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| Exact Sciences Corporation | 4 | $86 |
| Lilly USA, LLC | 4 | $84 |
| Amgen Inc. | 5 | $73 |
| Novo Nordisk Inc | 3 | $69 |
| PFIZER INC. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Eisai Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: AIRSUPRA, Ozempic, The Cologuard Plus Collection Kit, MOUNJARO, OTEZLA, JARDIANCE, TRELEGY ELLIPTA, FARXIGA.
Industry payments across FL — which companies pay providers there.
